Table 1 List of selected calcium channel blockers

From: Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing

Drugs

Class

Suggested primary target

Plasma half-life (human)

Crosses BBB

Nimodipine

Dihydropyridine

L-Type channel P/Q channel

1.7–9 h

Yes

Isradipine

Dihydropyridine

L-Type channel

8 h

Yes

Felodipine

Dihydropyridine

L-Type channel T-Type channel

8.5–19.7 h

Yes

Verapamil

Non-dihydropyridine (phenylalkylamine)

L-Type channel B-Type channel P/Q channel

2.8–7.4 h

No

Diltiazem

Non-dihydropyridine (benzothiazepine)

L-Type channel

3–4.5 h

Poor

Amlodipine

Dihydropyridine

L-Type channel

30–50 h

No

Nifedipine

Dihydropyridine

L-Type channel

2–7 ha

Yes

Nicardipine

Dihydropyridine

L-Type channel

8.6 h

Yes

Clevidipine

Dihydropyridine

L-Type channel

1 min

Yes

(2–15 min)

Nisoldipine

Dihydropyridine

L-Type channel

7–12 h

Yes

  1. The primary target human plasma half-life and BBB penetration information was obtained from PubChem (https://pubchem.ncbi.nlm.nih.gov/) and DrugBank (https://www.drugbank.ca/), accurate at the time of manuscript submission
  2. a7 h half-life determined from slow release formulation